These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 21453249)

  • 1. An updated patent review on ocular drug delivery systems with potential for commercial viability.
    Srivastava R; Pathak K
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):146-62. PubMed ID: 21453249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent patents on ocular drug delivery systems.
    Conway BR
    Recent Pat Drug Deliv Formul; 2008; 2(1):1-8. PubMed ID: 19075892
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent patents and advances in ophthalmic drug delivery.
    Janoria KG; Hariharan S; Dasari CR; Mitra AK
    Recent Pat Drug Deliv Formul; 2007; 1(2):161-70. PubMed ID: 19075883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent perspectives for corticosteroids based ophthalmic therapeutics.
    Suresh PK; Sah AK
    Recent Pat Drug Deliv Formul; 2014; 8(3):206-23. PubMed ID: 25020063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in ocular drug delivery.
    Rawas-Qalaji M; Williams CA
    Curr Eye Res; 2012 May; 37(5):345-56. PubMed ID: 22510004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ocular preparations: the formulation approach.
    Kaur IP; Kanwar M
    Drug Dev Ind Pharm; 2002 May; 28(5):473-93. PubMed ID: 12098838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of mucoadhesive drug delivery systems--an updated patent review.
    Maurya SK; Pathak K; Bali V
    Recent Pat Drug Deliv Formul; 2010 Nov; 4(3):256-65. PubMed ID: 20649509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
    Jiao J
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nanotechnology in ocular drug delivery.
    Sahoo SK; Dilnawaz F; Krishnakumar S
    Drug Discov Today; 2008 Feb; 13(3-4):144-51. PubMed ID: 18275912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ocular Drug Delivery - New Strategies for Targeting Anterior and Posterior Segments of the Eye.
    Fangueiro JF; Veiga F; Silva AM; Souto EB
    Curr Pharm Des; 2016; 22(9):1135-46. PubMed ID: 26675225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of ocular drug delivery.
    Sultana Y; Jain R; Aqil M; Ali A
    Curr Drug Deliv; 2006 Apr; 3(2):207-17. PubMed ID: 16611007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vesicular systems in ocular drug delivery: an overview.
    Kaur IP; Garg A; Singla AK; Aggarwal D
    Int J Pharm; 2004 Jan; 269(1):1-14. PubMed ID: 14698571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent patents on ophthalmic nanoformulations and therapeutic implications.
    Ako-Adounvo AM; Nagarwal RC; Oliveira L; Boddu SH; Wang XS; Dey S; Karla PK
    Recent Pat Drug Deliv Formul; 2014; 8(3):193-201. PubMed ID: 25262835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A New Direction in Ophthalmic Development: Nanoparticle Drug Delivery Systems.
    Andonova VY
    Curr Pharm Des; 2016; 22(41):6313-6329. PubMed ID: 27526789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colloidal drug delivery system: amplify the ocular delivery.
    Ali J; Fazil M; Qumbar M; Khan N; Ali A
    Drug Deliv; 2016; 23(3):710-26. PubMed ID: 24892625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fundamentals, challenges, and nanomedicine-based solutions for ocular diseases.
    Srinivasarao DA; Lohiya G; Katti DS
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2019 Jul; 11(4):e1548. PubMed ID: 30506871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel drug delivery systems for ocular therapy: With special reference to liposomal ocular delivery.
    Bhattacharjee A; Das PJ; Adhikari P; Marbaniang D; Pal P; Ray S; Mazumder B
    Eur J Ophthalmol; 2019 Jan; 29(1):113-126. PubMed ID: 29756507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled and continuous release ocular drug delivery systems: pros and cons.
    Abdelkader H; Alany RG
    Curr Drug Deliv; 2012 Jul; 9(4):421-30. PubMed ID: 22640036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microrobots: a new era in ocular drug delivery.
    Fusco S; Ullrich F; Pokki J; Chatzipirpiridis G; Özkale B; Sivaraman KM; Ergeneman O; Pané S; Nelson BJ
    Expert Opin Drug Deliv; 2014 Nov; 11(11):1815-26. PubMed ID: 25001411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contact lenses: promising devices for ocular drug delivery.
    Guzman-Aranguez A; Colligris B; Pintor J
    J Ocul Pharmacol Ther; 2013 Mar; 29(2):189-99. PubMed ID: 23215541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.